Vivus (VVUS) Tells Shareholders Its Open to Dissident Settlement - Bloomberg
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Tanker struck by projectile in Strait of Hormuz
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- AppLovin shares fall after court denies request against Unity
First Manhattan Updates on Shareholder Support for Director Change at Vivus (VVUS)
July 11, 2013 6:34 AM EDTFirst Manhattan Co., the owner of approximately 9.9% of the outstanding shares of VIVUS, Inc. (Vivus) (Nasdaq: VVUS), issued an open letter to Vivus' shareholders.
The full text of the letter follows:
July 11, 2013
Dear Fellow Vivus Shareholders:
We are pleased to report that our discussions with Vivus shareholders over these past several months have been very encouraging. We have received support from large and small shareholders alike. Shareholders have thanked us for our efforts to effect much needed change at Vivus. We share your sense... More
First Manhattan Gets More Support for Vivus (VVUS) Director Slate
July 11, 2013 6:30 AM EDTVivus, Inc. (Nasdaq: VVUS) shareholder QVT, its third-largest holder, is said to be backing the nine-director dissident slate for the company. The firm thinks that change needs to happen with the direction of the company, Bloomberg reports Thursday.
... More
VIVUS, Inc. (VVUS) Notes Positive Analyst Commentary Into Annual Meeting
July 10, 2013 7:47 AM EDTVIVUS, Inc. (Nasdaq: VVUS) issued the following statement in connection with the Company's 2013 Annual Meeting of Stockholders, which will be held on July 15, 2013:
VIVUS's July 15, 2013 Annual Meeting of Stockholders is fast approaching and it is extremely important that stockholders know the facts before they vote.
Despite First Manhattan Co's ("FMC") disruptive efforts, the VIVUS Board and management team are making meaningful progress toward unlocking the full potential of Qsymia (phentermine and topiramate extended-release) capsules CIV and STENDRA (avanafil) (SPEDRA in the European Union) and maximizing value for stockholders. Under the... More
